← Leaderboards
Philip E Thorpe
University Of Texas Sw Med Ctr/Dallas
$2,413,535
Attributed
$2,413,535
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $383.9K · FY2005–10$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$2,413,535 · 3
By mechanism
U01$2,413,535 · 2
P20$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Sw Med Ctr/Dallas
Same institution · by research overlap
- Michael J Gale$70,921,035
- Michelle D Tallquist$7,535,020
- Ronald G Victor$17,676,825
- Joseph L Goldstein$29,369,162
- Ralph Victor Shohet$20,048,453
Others in their field
Top investigators on “Phospholipids”
- Eugene W. St Clair · Duke University$24,182,181
- Valerian E Kagan · Wistar Institute$23,533,341
- Stanley J Opella · Wistar Institute$22,975,332
- Joel S. Bennett · University Of Pennsylvania$17,733,101
- George M. Carman · Rutgers The St Univ Of Nj New Brunswick$16,801,187
- Daniel E Kahne · Harvard University$16,303,151
Research focus
PhospholipidsVirus DiseasesAntiviral AgentsLassa VirusInfectionLassa FeverDrug Screening /EvaluationDisease /Disorder ModelCell MembraneDoseImmunogenicityImmunologic Substance Development /PreparationBinding (Molecular Function)In VitroBiomaterial Development /PreparationAntibodiesCellsBioterrorismBloodAnimal ModelArenavirusCaviaChimeric AntibodyDisease Progression
Grant awards (9)
Broad Spectrum Treatment of Hemmorrhagic Arenaviruses$383,917
U01 · FY2010 · AI · contact PI
Broad Spectrum Treatment of Hemmorrhagic Arenaviruses$378,616
U01 · FY2009 · AI · contact PI
Novel Anti-Viral Agents for Treating Lassa Fever$358,067
U01 · FY2007 · AI · contact PI
Novel Anti-Viral Agents for Treating Lassa Fever$358,981
U01 · FY2006 · AI · contact PI
Novel Anti-Viral Agents for Treating Lassa Fever$357,889
U01 · FY2005 · AI
Novel Anti-Viral Agents for Treating Lassa Fever$379,657
U01 · FY2004 · AI
Novel Anti-Viral Agents for Treating Lassa Fever$196,408
U01 · FY2003 · AI
NOVEL STRATEGIES FOR THERAPEUTIC VASCULAR TARGETING AGENTS$0
P20 · FY2002 · CA
NOVEL STRATEGIES FOR THERAPEUTIC VASCULAR TARGETING AGENTS$0
P20 · FY2001 · CA